Product NDC: | 60505-6031 |
Proprietary Name: | cefepime |
Non Proprietary Name: | cefepime |
Active Ingredient(s): | 2 g/1 & nbsp; cefepime |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-6031 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065369 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080314 |
Package NDC: | 60505-6031-4 |
Package Description: | 10 VIAL in 1 BOX (60505-6031-4) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 60505-6031-4 |
Proprietary Name | cefepime |
Package Description | 10 VIAL in 1 BOX (60505-6031-4) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 60505-6031 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefepime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080314 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | CEFEPIME HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |